CT47B1

Across TCGA pan-cancer cohorts, CT47B1 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated CT47B1 data layer compared with 6 for mutation status.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher CT47B1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated CT47B1 expression acts as an unfavorable survival marker.

KIRP, KICH, and READ are the cancer types where CT47B1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	DFS	Tertile	All	0.650	0.919	<.001	81	view →
KICH	OS	Tertile	All	0.082	0.877	<.001	78	view →
READ	OS	Tertile	IV	0.389	0.910	.001	57	view →
STAD	DFS	Tertile	IV	0.097	0.412	.008	36	view →
DLBC	OS	Tertile	III,IV	0.175	0.874	.025	36	view →
UCS	DFS	Tertile	IV	0.230	0.767	.009	36	view →
ACC	OS	Tertile	All	0.701	0.890	.015	27	view →
LIHC	DFS	Tertile	All	0.340	0.463	.014	21	view →
SCLC	DFS	Tertile	All	0.192	0.793	.017	18	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

CT47B1–KIRP (DFS)

Open the KIRP breakdown →